Patents by Inventor Hendrikus Antonius Rudolfus VAN WYK

Hendrikus Antonius Rudolfus VAN WYK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense oligonucleotides for the treatment of usher syndrome type 2
    Patent number: 11414662
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher syndrome type 2A and/or USH2A-associated non syndromic retina degeneration.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: August 16, 2022
    Assignee: Stichting Radboud universitair medisch centum
    Inventor: Hendrikus Antonius Rudolfus Van Wyk
  • ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME TYPE 2
    Publication number: 20210123050
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher syndrome type 2A and/or USH2A-associated non syndromic retina degeneration.
    Type: Application
    Filed: July 10, 2020
    Publication date: April 29, 2021
    Inventor: Hendrikus Antonius Rudolfus Van Wyk
  • Minigene for the treatment of Usher syndrome type 2a and USH2A-associated retinitis pigmentosa.
    Publication number: 20210087583
    Abstract: The present invention relates to the field of medicine. In particular, it relates to therapy for the treatment of Usher syndrome type 2a and USH2A-associated retinitis pigmentosa.
    Type: Application
    Filed: February 28, 2019
    Publication date: March 25, 2021
    Applicant: Stichting Katholieke Universiteit
    Inventors: Hendrikus Antonius Rudolfus van Wyk, Johanna Maria Josephina Kremer
  • ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME TYPE 2
    Publication number: 20190017048
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher syndrome type 2A and/or USH2A-associated non syndromic retina degeneration.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 17, 2019
    Applicant: STICHTING KATHOLIEKE UNIVERSITEIT
    Inventor: Hendrikus Antonius Rudolfus VAN WYK
  • Antisense oligonucleotides for the treatment of Usher syndrome type 2
    Patent number: 10131910
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher syndrome type 2A and/or USH2A-associated non syndromic retina degeneration.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: November 20, 2018
    Assignee: STICHTING KATHOLIEKE UNIVERSITEIT
    Inventor: Hendrikus Antonius Rudolfus Van Wyk
  • ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME TYPE 2
    Publication number: 20170159052
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher syndrome type 2A and/or USH2A-associated non syndromic retina degeneration.
    Type: Application
    Filed: July 9, 2015
    Publication date: June 8, 2017
    Applicant: STICHTING KATHOLIEKE UNIVERSITEIT
    Inventor: Hendrikus Antonius Rudolfus VAN WYK